We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.46B Turnover 16.47%
1-Year Est. Return 32.78%
This Fund
S&P 500
This Quarter Est. Return
-1.64%
1 Year Est. Return
+32.78%
3 Year Est. Return
+114.54%
5 Year Est. Return
+163.28%
10 Year Est. Return
+573.7%
AUM
$2.27B
AUM Growth
-$145M
Cap. Flow
-$38M
Cap. Flow %
-1.67%
Top 10 Hldgs %
17.52%
Holding
260
New
17
Increased
70
Reduced
153
Closed
18
Avg Time Held
3.1 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
BRO icon
Brown & Brown
BRO
+$35.9M
2
CPRT icon
Copart
CPRT
+$33.8M
3
ABBV icon
AbbVie
ABBV
+$28.7M
4
EME icon
Emcor
EME
+$27.3M
5
MCO icon
Moody's
MCO
+$26.4M

Top Sells

Rank Stock Value
1
PWR icon
Quanta Services
PWR
+$35.9M
2
MAR icon
Marriott International
MAR
+$35M
3
HON icon
Honeywell
HON
+$34M
4
SHW icon
Sherwin-Williams
SHW
+$30.6M
5
FERG icon
Ferguson
FERG
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 32.11%
2 Financials 16.06%
3 Healthcare 12.58%
4 Industrials 11.15%
5 Consumer Discretionary 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AER icon
76
AerCap
AER
$22.9B
$6.33M 0.28%
61,997
-7,604
-11% -$753K
2024 Q2
3 quarters
SHEL icon
77
Shell
SHEL
$295B
$6.23M 0.27%
85,017
-10,999
-11% -$741K
2022 Q2
11 quarters
TXRH icon
78
Texas Roadhouse
TXRH
$11.2B
$6.18M 0.27%
37,078
+6,770
+22% +$1.2M
2021 Q3
14 quarters
KNSL icon
79
Kinsale Capital Group
KNSL
$8.14B
$6.16M 0.27%
12,652
+2,305
+22% +$1.03M
2021 Q2
15 quarters
KT icon
80
KT
KT
$8.79B
$6.12M 0.27%
+345,618
New +$5.96M
2025 Q1
0 quarters
CPRX icon
81
DELISTED
Catalyst Pharmaceutical
CPRX
$6.12M 0.27%
252,285
+49,525
+24% +$1.12M
2024 Q4
1 quarter
LNTH icon
82
Lantheus
LNTH
$6.53B
$6.06M 0.27%
62,094
+11,555
+23% +$1.08M
2023 Q1
8 quarters
QTWO icon
83
Q2 Holdings
QTWO
$3.88B
$5.85M 0.26%
73,087
+13,776
+23% +$1.22M
2024 Q1
4 quarters
SNY icon
84
Sanofi
SNY
$96.5B
$5.83M 0.26%
105,143
-12,483
-11% -$676K
2022 Q3
10 quarters
GIL icon
85
Gildan
GIL
$7.78B
$5.8M 0.26%
131,239
-15,795
-11% -$785K
2024 Q3
2 quarters
ENSG icon
86
The Ensign Group
ENSG
$10.4B
$5.71M 0.25%
44,158
+15,701
+55% +$2.08M
2024 Q1
4 quarters
JAZZ icon
87
Jazz Pharmaceuticals
JAZZ
$13.9B
$5.47M 0.24%
+44,060
New +$5.75M
2025 Q1
0 quarters
MMSI icon
88
Merit Medical Systems
MMSI
$5.35B
$5.4M 0.24%
51,068
+9,081
+22% +$937K
2023 Q1
8 quarters
GIB icon
89
CGI
GIB
$15.5B
$5.31M 0.23%
53,162
-6,720
-11% -$737K
2018 Q4
25 quarters
VRRM icon
90
Verra Mobility
VRRM
$447M
$5.2M 0.23%
231,096
+40,748
+21% +$981K
2024 Q1
4 quarters
RELY icon
91
Remitly
RELY
$5.22B
$5.18M 0.23%
249,197
+43,983
+21% +$1.01M
2024 Q4
1 quarter
VITL icon
92
Vital Farms
VITL
$367M
$5.05M 0.22%
165,761
+29,626
+22% +$1.07M
2024 Q3
2 quarters
HQY icon
93
HealthEquity
HQY
$7.65B
$5.02M 0.22%
56,811
+10,071
+22% +$1.03M
2023 Q4
5 quarters
SPSC icon
94
SPS Commerce
SPSC
$3.13B
$5.02M 0.22%
37,804
+17,379
+85% +$2.73M
2022 Q2
11 quarters
TSEM icon
95
Tower Semiconductor
TSEM
$23.7B
$4.92M 0.22%
137,956
-78,718
-36% -$3.56M
2020 Q2
19 quarters
RMBS icon
96
Rambus
RMBS
$10.1B
$4.85M 0.21%
93,665
+17,776
+23% +$1.04M
2024 Q2
3 quarters
FLEX icon
97
Flex
FLEX
$36.4B
$4.78M 0.21%
144,426
-69,677
-33% -$2.73M
2024 Q3
2 quarters
NXPI icon
98
NXP Semiconductors
NXPI
$58.3B
$4.76M 0.21%
25,061
-3,358
-12% -$716K
2015 Q1
40 quarters
NMIH icon
99
NMI Holdings
NMIH
$3.02B
$4.74M 0.21%
131,417
+24,083
+22% +$876K
2020 Q3
18 quarters
VET icon
100
Vermilion Energy
VET
$1.93B
$4.68M 0.21%
577,986
-84,677
-13% -$756K
2021 Q3
14 quarters

Similar funds

Renaissance Group's Q1 2025 Portfolio in Review

As of Q1 2025, Renaissance Group held 260 positions worth $2.27B, down 6% from $2.41B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Renaissance Group's Q1 2025 filing shows 17 new, 70 increased, 153 reduced and 18 closed positions. Its largest new stake was Brown & Brown: 320,889 shares worth $39.9M. The largest sale was Quanta Services, an estimated $35.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

  • Renaissance Group's largest Q1 2025 buy was Brown & Brown: 320,889 shares worth $39.9M.
  • Renaissance Group added most to AbbVie in Q1 2025, an estimated $28.7M increase.
  • Renaissance Group's biggest Q1 2025 reduction was Marriott International, cutting an estimated $35M.
  • Renaissance Group fully exited Quanta Services in Q1 2025, selling an estimated $35.9M.
  • Renaissance Group's ten largest holdings make up 18% of its $2.27B portfolio in Q1 2025.
  • Renaissance Group opened 17 new positions and closed 18 in Q1 2025.
  • Renaissance Group's portfolio value fell 6% quarter-over-quarter to $2.27B.

Based on Renaissance Group's 13F filing for Q1 2025, filed 13 May 2025.